T2 Biosystems Revenue vs. Number Of Shares Shorted
| TTOODelisted Stock | USD 0.18 0.05 21.74% |
For T2 Biosystems profitability analysis, we use financial ratios and fundamental drivers that measure the ability of T2 Biosystems to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well T2 Biosystems utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between T2 Biosystems's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of T2 Biosystems over time as well as its relative position and ranking within its peers.
TTOO |
T2 Biosystems Number Of Shares Shorted vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining T2 Biosystems's current stock value. Our valuation model uses many indicators to compare T2 Biosystems value to that of its competitors to determine the firm's financial worth. T2 Biosystems is rated below average in revenue category among its peers. It is rated below average in number of shares shorted category among its peers making about 0.11 of Number Of Shares Shorted per Revenue. The ratio of Revenue to Number Of Shares Shorted for T2 Biosystems is roughly 8.70 . Comparative valuation analysis is a catch-all model that can be used if you cannot value T2 Biosystems by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for T2 Biosystems' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.TTOO Revenue vs. Competition
T2 Biosystems is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 78.09 Billion. T2 Biosystems adds roughly 7.19 Million in revenue claiming only tiny portion of equities under Health Care industry.
TTOO Number Of Shares Shorted vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
T2 Biosystems |
| = | 7.19 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
T2 Biosystems |
| = | 826.91 K |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
TTOO Number Of Shares Shorted Comparison
T2 Biosystems is currently under evaluation in number of shares shorted category among its peers.
T2 Biosystems Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in T2 Biosystems, profitability is also one of the essential criteria for including it into their portfolios because, without profit, T2 Biosystems will eventually generate negative long term returns. The profitability progress is the general direction of T2 Biosystems' change in net profit over the period of time. It can combine multiple indicators of T2 Biosystems, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. T2 Biosystems operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 182 people.
TTOO Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on T2 Biosystems. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of T2 Biosystems position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the T2 Biosystems' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in T2 Biosystems without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Use Investing Themes to Complement your T2 Biosystems position
In addition to having T2 Biosystems in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run JPY Crypto Assets Thematic Idea Now
JPY Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in Japanese Yen. The JPY Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize JPY Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystems' history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |